Exsilio Therapeutics logo

Exsilio Therapeutics

Boston, MA

Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells.

exsiliotx.com

Company Details

Founded

2022

Employees

Between 10 - 50 employees

Raised

$82,000,000

Headquarters Location

Boston, MA

Public

No

Acquired

No

CEO

Tal ZaksTal Zaks

Company Collections

These are collections Exsilio Therapeutics is a part of. Click on the collection name to view similar companies.

Exsilio Therapeutics' Industries

Exsilio Therapeutics' Investors